Latest News about GKOS
Recent news which mentions GKOS
   Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  September 07, 2022
  From Benzinga
 
   Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
   
  
  
  September 07, 2022
  From Benzinga
 
   Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
   
  September 07, 2022
  Tickers 
   GKOS
  
  
  From Benzinga
 
   Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment
   
  August 24, 2022
  Tickers 
   GKOS
  
  
  From Benzinga
 
   Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
   
  
  
  August 03, 2022
  From Benzinga
 
   Glaukos Receives FDA 510(k) Clearance For iStent infinite
   
  August 03, 2022
  Tickers 
   GKOS
  
  
  From Benzinga
 
   The 6 Most Aggressive Growth Stocks to Buy in July
   
  
  
  July 12, 2022
  From InvestorPlace
 From Benzinga
 
   Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View
   
  
  
  March 25, 2022
  From Benzinga
 
   Earnings Scheduled For February 22, 2022
   
  
  
  February 22, 2022
  From Benzinga
 
   The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
   
  
  
  February 20, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
   
  
  
  February 03, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
   
  
  
  January 19, 2022
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  January 12, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
   
  
  
  January 12, 2022
  From Benzinga
 
   Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety Profile
   
  January 12, 2022
  Tickers 
   GKOS
  
  
  From Benzinga
 
   The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
   
  
  
  January 07, 2022
  From Benzinga
 From Benzinga
 
   5 Stocks To Watch For January 7, 2022
   
  
  
  January 07, 2022
  From Benzinga
 
   Glaukos Corp (GKOS) FY 2021 Earnings Call Transcript
   
  November 30, 2021
  Tickers 
   GKOS
  
  
  From Motley Fool
 
   FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure
   
  
  
  November 11, 2021
  From Benzinga
 
   Glaukos Corp (GKOS) Q3 2021 Earnings Call Transcript
   
  November 07, 2021
  Tickers 
   GKOS
  
  
  From Motley Fool
 
   The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
   
  
  
  November 04, 2021
  From Benzinga
 
   86 Biggest Movers From Yesterday
   
  
  
  November 04, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.